ArticleOncotarget2018

Efficacy and safety of sorafenib for advanced renal cell carcinoma: real-world data of patients with renal impairment.

Katsunori Tatsugami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.